Overview
- The first book to focus on ethical issues associated with antimicrobial resistance
- Including theoretical/conceptual approaches, in-context analysis of specific topics, and interdisciplinary perspectives
- Authors include world-leading figures in bioethics, public health ethics, law, epidemiology, and economics
- Critically addresses trade-offs required in response to a growing problem predicted to kill more people than cancer by 2050
- Essential reading for scholars in bioethics and public health ethics, physicians, public health practitioners, and policy makers
Part of the book series: Public Health Ethics Analysis (PHES, volume 5)
Buy print copy
Tax calculation will be finalised at checkout
Table of contents (26 chapters)
-
Front Matter
-
Ethics and Drug Resistance in Context
-
Front Matter
-
-
Theoretical Approaches to Ethics and Drug Resistance
-
Front Matter
-
Keywords
- antimicrobial resistance
- public health ethics
- collective responsibility
- infectious disease
- global health
- hospital acquired infection
- animal ethics
- animal epidemiology
- TB resistance and human rights
- TB resistance in developing countries
- privacy and data collection
- ethics and AMR regulation
- ethics of drug development
- antibacterial drug resistance
- infectious diseases
About this book
This Open Access volume provides in-depth analysis of the wide range of ethical issues associated with drug-resistant infectious diseases. Antimicrobial resistance (AMR) is widely recognized to be one of the greatest threats to global public health in coming decades; and it has thus become a major topic of discussion among leading bioethicists and scholars from related disciplines including economics, epidemiology, law, and political theory. Topics covered in this volume include responsible use of antimicrobials; control of multi-resistant hospital-acquired infections; privacy and data collection; antibiotic use in childhood and at the end of life; agricultural and veterinary sources of resistance; resistant HIV, tuberculosis, and malaria; mandatory treatment; and trade-offs between current and future generations. As the first book focused on ethical issues associated with drug resistance, it makes a timely contribution to debates regarding practice and policy that are of crucial importance to global public health in the 21st century.
Editors and Affiliations
About the editors
Doctor Euzebiusz Jamrozik is a practising physician and bioethics PhD candidate in the Monash Bioethics Centre at Monash University, where he also completed an MA in Bioethics after prior studies in medicine and philosophy at University of Western Australia. His multidisciplinary interests include infectious disease, public health ethics, and epidemiology. Among other topics, his recent publications focus on ethical implications of vaccination, vector-borne disease, human challenge studies, and climate change impact on infectious disease. He is a Fellow of the Royal Australasian College of Physicians (FRACP) and Member of the World Health Organization (WHO) Collaborating Centre for Bioethics at Monash University.
Professor Michael Selgelid is Director of the Monash Bioethics Centre and the World Health Organization (WHO) Collaborating Centre for Bioethics at Monash University in Melbourne, Australia. His research primarily focuses on public health ethics, infectious disease ethics, research ethics, and ethical issues associated with biotechnology and other emerging technologies. He edits a book series in Public Health Ethics Analysis for Springer and is Co-Editor of Monash Bioethics Review. Michael earned a BS in Biomedical Engineering from Duke University and a PhD in Philosophy from the University of California, San Diego.
Bibliographic Information
Book Title: Ethics and Drug Resistance: Collective Responsibility for Global Public Health
Editors: Euzebiusz Jamrozik, Michael Selgelid
Series Title: Public Health Ethics Analysis
DOI: https://doi.org/10.1007/978-3-030-27874-8
Publisher: Springer Cham
eBook Packages: Religion and Philosophy, Philosophy and Religion (R0)
Copyright Information: The Editor(s) (if applicable) and The Author(s) 2020
Hardcover ISBN: 978-3-030-27873-1Published: 27 October 2020
Softcover ISBN: 978-3-030-27876-2Published: 21 August 2021
eBook ISBN: 978-3-030-27874-8Published: 26 October 2020
Series ISSN: 2211-6680
Series E-ISSN: 2211-6699
Edition Number: 1
Number of Pages: XVII, 448
Number of Illustrations: 1 b/w illustrations
Topics: Bioethics, Drug Resistance, Infectious Diseases